6.
Deepak K, Roy P, Kola P, Mukherjee B, Mandal M
. An overview of kinin mediated events in cancer progression and therapeutic applications. Biochim Biophys Acta Rev Cancer. 2022; 1877(6):188807.
DOI: 10.1016/j.bbcan.2022.188807.
View
7.
Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D
. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021; 23(8):1231-1251.
PMC: 8328013.
DOI: 10.1093/neuonc/noab106.
View
8.
Strzalka-Mrozik B, Stanik-Walentek A, Kapral M, Kowalczyk M, Adamska J, Gola J
. Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas. Mol Vis. 2010; 16:161-6.
PMC: 2817012.
View
9.
Orchel J, Witek L, Kimsa M, Strzalka-Mrozik B, Kimsa M, Olejek A
. Expression patterns of kinin-dependent genes in endometrial cancer. Int J Gynecol Cancer. 2012; 22(6):937-44.
DOI: 10.1097/IGC.0b013e318259d8da.
View
10.
Guevara-Lora I
. Kinin-mediated inflammation in neurodegenerative disorders. Neurochem Int. 2012; 61(1):72-8.
DOI: 10.1016/j.neuint.2012.04.013.
View
11.
Pillat M, Oliveira M, Motaln H, Breznik B, Glaser T, Lah T
. Glioblastoma-mesenchymal stem cell communication modulates expression patterns of kinin receptors: Possible involvement of bradykinin in information flow. Cytometry A. 2015; 89(4):365-75.
DOI: 10.1002/cyto.a.22800.
View
12.
Lu D, Leung Y, Huang S, Wong K
. Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells. J Cell Biochem. 2010; 110(1):141-50.
DOI: 10.1002/jcb.22520.
View
13.
Larysz D, Kula D, Kowal M, Rudnik A, Jarzab M, Blamek S
. Epidermal growth factor receptor gene expression in high grade gliomas. Folia Neuropathol. 2011; 49(1):28-38.
View
14.
Ifuku M, Farber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C
. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci. 2007; 27(48):13065-73.
PMC: 6673405.
DOI: 10.1523/JNEUROSCI.3467-07.2007.
View
15.
Oliveira M, Breznik B, Pillat M, Pereira R, Ulrich H, Lah T
. Kinins in Glioblastoma Microenvironment. Cancer Microenviron. 2019; 12(2-3):77-94.
PMC: 6937362.
DOI: 10.1007/s12307-019-00229-x.
View
16.
Joseph K, Kaplan A
. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol. 2005; 86:159-208.
DOI: 10.1016/S0065-2776(04)86005-X.
View
17.
Marceau F, Bachelard H, Bouthillier J, Fortin J, Morissette G, Bawolak M
. Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. Int Immunopharmacol. 2020; 82:106305.
DOI: 10.1016/j.intimp.2020.106305.
View
18.
Tan A, Ashley D, Lopez G, Malinzak M, Friedman H, Khasraw M
. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020; 70(4):299-312.
DOI: 10.3322/caac.21613.
View
19.
Raidoo D, Sawant S, Mahabeer R, Bhoola K
. Kinin receptors are expressed in human astrocytic tumour cells. Immunopharmacology. 1999; 43(2-3):255-63.
DOI: 10.1016/s0162-3109(99)00097-1.
View
20.
Bryant J, Shariat-Madar Z
. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem. 2009; 7(3):234-50.
PMC: 4905712.
DOI: 10.2174/187152509789105444.
View